The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

B Vogel, M Acevedo, Y Appelman, CNB Merz… - The Lancet, 2021 - thelancet.com
Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …

The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

MF Osuchowski, MS Winkler, T Skirecki… - The Lancet …, 2021 - thelancet.com
The zoonotic SARS-CoV-2 virus that causes COVID-19 continues to spread worldwide, with
devastating consequences. While the medical community has gained insight into the …

[HTML][HTML] Emerging variants of SARS-CoV-2 and novel therapeutics against coronavirus (COVID-19)

A Aleem, AS Ab, AK Slenker - 2021 - europepmc.org
Objectives: Describe the clinical manifestations, including extrapulmonary manifestations of
COVID-19. Outline the latest treatments available in the management of COVID-19 …

Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves

BKJ Tan, R Han, JJ Zhao, NKW Tan, ESH Quah… - bmj, 2022 - bmj.com
Objective To clarify in patients with covid-19 the recovery rate of smell and taste, proportion
with persistent dysfunction of smell and taste, and prognostic factors associated with …

Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: the LONG-COVID-EXP-CM multicenter study

C Fernández-de-Las-Peñas… - Journal of clinical …, 2022 - mdpi.com
This multicenter cohort study investigated the differences between coronavirus disease
2019 (COVID-19) related symptoms and post-COVID symptoms between male and female …

BNT162b2 vaccination induces durable SARS-CoV-2–specific T cells with a stem cell memory phenotype

G Guerrera, M Picozza, S D'Orso, R Placido… - Science …, 2021 - science.org
Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
effective in preventing hospitalization from severe COVID-19. However, multiple reports of …

[HTML][HTML] Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients

M Peghin, A Palese, M Venturini, M De Martino… - Clinical Microbiology …, 2021 - Elsevier
Objectives To assess the prevalence of and factors associated with post-coronavirus
disease 2019 (COVID-19) syndrome 6 months after the onset. Methods A bidirectional …

Sex differences in immune responses that underlie COVID-19 disease outcomes

T Takahashi, MK Ellingson, P Wong, B Israelow… - Nature, 2020 - nature.com
There is increasing evidence that coronavirus disease 2019 (COVID-19) produces more
severe symptoms and higher mortality among men than among women,,,–. However …

[HTML][HTML] Features, evaluation, and treatment of coronavirus (COVID-19)

M Cascella - 2020 - ncbi.nlm.nih.gov
Objectives: Screen individuals based on exposure and symptom criteria to identify potential
COVID-19 cases. Identify the clinical features and radiological findings expected in patients …

An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies

HF Tsang, LWC Chan, WCS Cho, ACS Yu… - Expert review of anti …, 2021 - Taylor & Francis
Introduction To date, the transmission of Coronavirus Disease-2019 (COVID-19) is still
uncontrollable with the fact that the numbers of confirmed and death cases are still …